| 38091020 | Benign Breast Disease and Breast Cancer Risk in the Percutaneous Biopsy Era. | JAMA Surg | 2024 |
| 36380012 | Immune cells are increased in normal breast tissues of BRCA1/2 mutation carriers. | Breast Cancer Res Treat | 2023 |
| 37856151 | Age-Dependent Sex Differences in the Prevalence of Selective Serotonin Reuptake Inhibitor Treatment: A Retrospective Cohort Analysis. | J Womens Health (Larchmt) | 2023 |
| 37585518 | Leadership Development in Early Career Scientists: Themes and Feedback from Executive Coaching and Mindful Leadership Training. | J Womens Health (Larchmt) | 2023 |
| 36948887 | p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study. | J Pathol Clin Res | 2023 |
| 37172561 | Quality control and analytic best practices for testing genetic models of sex differences in large populations. | Cell | 2023 |
| 37104728 | Impact of Artificial Intelligence System and Volumetric Density on Risk Prediction of Interval, Screen-Detected, and Advanced Breast Cancer. | J Clin Oncol | 2023 |
| 37228751 | Toward a deeper understanding of gene-by-sex interaction models. | Cell Genom | 2023 |
| 36965208 | Pharmacotherapy exposure as a marker of disease complexity in bipolar disorder: Associations with clinical & genetic risk factors. | Psychiatry Res | 2023 |
| 36790339 | Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma. | Cancer Epidemiol Biomarkers Prev | 2023 |
| 36919637 | Polygenic prediction of bipolar disorder in a Latin American sample. | Am J Med Genet B Neuropsychiatr Genet | 2023 |
| 36719088 | The Interaction Between Brain-Derived Neurotrophic Factor Levels and Alcohol Consumption, Sleep Disturbance and Sex-Hormones in Alcohol Use Disorders. | Alcohol Alcohol | 2023 |
| 36572991 | CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study. | Cancer | 2023 |
| 36701934 | Associations of sex-related steroid hormones and proteins with alcohol dependence: A United Kingdom Biobank study. | Drug Alcohol Depend | 2023 |
| 36596665 | Benign Breast Disease, NSAIDs, and Postmenopausal Breast Cancer Risk in the CPS-II Cohort. | Cancer Prev Res (Phila) | 2023 |
| 34782936 | MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma. | Virchows Arch | 2022 |
| 35545158 | Quantification of diet quality utilizing the rapid eating assessment for participants-shortened version in bipolar disorder: Implications for prospective depression and cardiometabolic studies. | J Affect Disord | 2022 |
| 35503494 | Serum hormone levels and normal breast histology among premenopausal women. | Breast Cancer Res Treat | 2022 |
| 35400525 | Germline BRCA variants, lifestyle and ovarian cancer survival. | Gynecol Oncol | 2022 |
| 35821041 | Towards defining morphologic parameters of normal parous and nulliparous breast tissues by artificial intelligence. | Breast Cancer Res | 2022 |
| 35454861 | CA-125 Levels Are Predictive of Survival in Low-Grade Serous Ovarian Cancer-A Multicenter Analysis. | Cancers (Basel) | 2022 |
| 35418701 | Genome-wide interaction analysis of menopausal hormone therapy use and breast cancer risk among 62,370 women. | Sci Rep | 2022 |
| 35816189 | Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and Outcomes. | Clin Cancer Res | 2022 |
| 35780966 | The genetics of bipolar disorder with obesity and type 2 diabetes. | J Affect Disord | 2022 |
| 36456881 | The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer. | Nat Genet | 2022 |
| 35931468 | Into the future: A pilot study combining imaging with molecular profiling to predict resectability in ovarian cancer. | Gynecol Oncol | 2022 |
| 36303815 | A genome-wide gene-based gene-environment interaction study of breast cancer in more than 90,000 women. | Cancer Res Commun | 2022 |
| 36160147 | Computational tumor stroma reaction evaluation led to novel prognosis-associated fibrosis and molecular signature discoveries in high-grade serous ovarian carcinoma. | Front Med (Lausanne) | 2022 |
| 36344993 | A genome-wide association study of mammographic texture variation. | Breast Cancer Res | 2022 |
| 36114500 | Quality control recommendations for RNASeq using FFPE samples based on pre-sequencing lab metrics and post-sequencing bioinformatics metrics. | BMC Med Genomics | 2022 |
| 35046392 | Automated quantification of levels of breast terminal duct lobular (TDLU) involution using deep learning. | NPJ Breast Cancer | 2022 |
| 34789471 | High Prediagnosis Inflammation-Related Risk Score Associated with Decreased Ovarian Cancer Survival. | Cancer Epidemiol Biomarkers Prev | 2022 |
| 34697060 | DNA Methylation Profiles of Ovarian Clear Cell Carcinoma. | Cancer Epidemiol Biomarkers Prev | 2022 |
| 32546565 | Population-based targeted sequencing of 54 candidate genes identifies <i>PALB2</i> as a susceptibility gene for high-grade serous ovarian cancer. | J Med Genet | 2021 |
| 33648717 | Examining Sex-Differentiated Genetic Effects Across Neuropsychiatric and Behavioral Traits. | Biol Psychiatry | 2021 |
| 33733051 | Association of Daily Alcohol Intake, Volumetric Breast Density, and Breast Cancer Risk. | JNCI Cancer Spectr | 2021 |
| 34916903 | Plasma Cell-Free DNA Methylomics of Bipolar Disorder With and Without Rapid Cycling. | Front Neurosci | 2021 |
| 34857937 | What about sex? | Nat Metab | 2021 |
| 34519572 | Fully Automated Volumetric Breast Density Estimation from Digital Breast Tomosynthesis. | Radiology | 2021 |
| 34491131 | Deep Learning Predicts Interval and Screening-detected Cancer from Screening Mammograms: A Case-Case-Control Study in 6369 Women. | Radiology | 2021 |
| 34771660 | Incorporating Robustness to Imaging Physics into Radiomic Feature Selection for Breast Cancer Risk Estimation. | Cancers (Basel) | 2021 |
| 34161135 | Mammographic Variation Measures, Breast Density, and Breast Cancer Risk. | AJR Am J Roentgenol | 2021 |
| 34274690 | Deep-LIBRA: An artificial-intelligence method for robust quantification of breast density with independent validation in breast cancer risk assessment. | Med Image Anal | 2021 |
| 34125586 | Randomized, Double-Blind Trial on the Impact of Word Count in Cancer Clinical Trial Consent Forms. | JCO Oncol Pract | 2021 |
| 34146516 | Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element. | Am J Hum Genet | 2021 |
| 34261476 | Somatic mutations in benign breast disease tissues and association with breast cancer risk. | BMC Med Genomics | 2021 |
| 34082482 | Testing and estimation of X-chromosome SNP effects: Impact of model assumptions. | Genet Epidemiol | 2021 |
| 34162658 | Identification of a Locus Near <i>ULK1</i> Associated With Progression-Free Survival in Ovarian Cancer. | Cancer Epidemiol Biomarkers Prev | 2021 |
| 34355204 | Large-scale cross-cancer fine-mapping of the 5p15.33 region reveals multiple independent signals. | HGG Adv | 2021 |
| 33277321 | Simplified Breast Risk Tool Integrating Questionnaire Risk Factors, Mammographic Density, and Polygenic Risk Score: Development and Validation. | Cancer Epidemiol Biomarkers Prev | 2021 |